Table 2.

Laboratory and biochemical data

Age (years)	Laboratory references
	Hb	PLT	AST	ALT	INR	AFP	D-/L-arabitol enantiomer ratio
	0–2 weeks, 14.9–23.7; 2 weeks–2 months, 13.4–9.8; 2–6 months, 9.4–13; 6 months–1 year, 11.1–14.1; 1–2 years, 11.3–14.1; 2–6 years, 11.5–13.5; 6–12 years, 11.5–15.5; 12–18 years, boys, 13–16 mg/dL	150–450 × 103/μL	<52 U/L	<18 months, N < 55/60 U/L; 18 months–12 years, boys, N < 40 U/L; >12 years, boys, N < 26 U/L	0.9–1.2	<5.0 IU/mL	<3.0 mmol/mol creatinine
Patient I
1.3	11.2–12.0	47	141–258	68–146	1.49	2,100	n.a.
3.5	12.5	80	173–190	95–136	1.52–1.87	620	14.5
5.5	10.2–11.5	59	82	44	1.34	57.4	9.15
7.5	8.2–10.4	59–71	66–132	27–40	1.31–1.45	n.a.	n.a.
10.0	11.3	83	76	36	1.48	7.5	n.a.
11.0	10.4	75	109	62	1.48	5.4	8.2
12.5	11.1	99	91	66	1.51	5.1	n.a.
Patient II
0.1	8.6	104	55–84	66–87	n.a.	45,450	n.a.
0.4	11.2	116	94	105	1.27	21,618	13.0
1.8	8.7	78	277	113	2.08	n.a.	n.a.
4.5	10.7–11.4	83	227	82	1.60	n.a.	n.a.
6.0	10.0	155	258	80	1.56	64.1	n.a.
8.0	12.4	127	115	58	1.53	44.3	7.8
9.5	13.5	126	139	65	1.51	31.6	n.a.
Patient III
0.1	11.2–15.9	31–125	90	72	1.88	n.a.	8.50
0.7	11.3	117	71	39	1.85	n.a.	8.37
1.0	11.1	126	133	60	1.32	49.3	n.a.
2.0	11.6	101	58	38	1.23	44.8	n.a.
7.0	11.6	106	28	16	1.10	4.62	7.5
Patient IV
0.1	11.1	35	84–97	24–30	1.92	n.a.	n.a.
0.3	11.5	66	72	33	1.49	n.a.	n.a.
1.0	12.0	64	168	50	1.81	278	n.a.
1.4	12.6	59	163	42	1.65	n.a.	13.2
2.0	11.6	85	192	45	1.69	150	11.7
4.0	11.2	63	213	55	1.50	102	n.a.